Kelee Petzelt, MA, is Vice President of Sales at Synerio. Kelee is a Pharmacogenomic SME and author of blogs and publications focused on implementing pharmacy-guided PGx solutions into the workflow. She serves as the Risk Evaluation and Mitigation Strategies (REMS) Use Case Coordinator for CodeX, leveraging HL7 FHIR© to exchange data to support the safe use of FDA-approved medications. Kelee is actively involved in NASP, NCPDP, Asembia, NCPA and NACDS.